Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Moodys
Deloitte
Dow
Chinese Patent Office
Argus Health
Novartis
Healthtrust
Mallinckrodt

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017743

« Back to Dashboard
NDA 017743 describes BREVICON 28-DAY, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from one supplier. Additional details are available on the BREVICON 28-DAY profile page.

The generic ingredient in BREVICON 28-DAY is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for NDA: 017743

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017743

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BREVICON 28-DAY
ethinyl estradiol; norethindrone
TABLET;ORAL-28 017743 NDA Actavis Pharma, Inc. 52544-254 52544-254-28 3 BLISTER PACK in 1 CARTON (52544-254-28) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG;0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Argus Health
Boehringer Ingelheim
Daiichi Sankyo
UBS
Mallinckrodt
Cerilliant
Colorcon
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot